COMMUNIQUÉS West-GlobeNewswire

-
Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177
09/07/2018 -
Zafgen and the Foundation for Prader-Willi Research Announce PATH for PWS Natural History Study
09/07/2018 -
Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma
09/07/2018 -
Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands
09/07/2018 -
Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington’s Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
09/07/2018 -
Nkarta Therapeutics Expands Management Team and Establishes New Corporate Headquarters
09/07/2018 -
Biotricity Provides Fiscal 2018 First Quarter Updates for Shareholders
09/07/2018 -
Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs
09/07/2018 -
Nephros Announces Preliminary Financial Results for Second Quarter 2018
09/07/2018 -
Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
09/07/2018 -
Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection
09/07/2018 -
Quark Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
09/07/2018 -
Tauriga Sciences, Inc. Successfully Petitions OTC MARKETS GROUP to Expedite the Up-Lisitng of its Shares to the OTCQB Exchange
09/07/2018 -
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
09/07/2018 -
Amryt Pharma plc: NHS England approves funding for Lojuxta
09/07/2018 -
FDA grants Fast Track Designation to Aclaris Therapeutics’ Investigational JAK Inhibitor for the treatment of Alopecia Areata
09/07/2018 -
Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific
09/07/2018 -
Sunesis Pharmaceuticals Strengthens Senior Management Team
09/07/2018 -
Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1x1 Day
09/07/2018
Pages